Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Azitra Inc

AZTR
Current price
0.51 USD -0.014 USD (-2.69%)
Last closed 0.49 USD
Company
ISIN unknown
Sector Healthcare
Industry Biotechnology
Exchange NYSE
Capitalization 3 702 452 USD
Yield for 12 month -99.04 %
1Y
3Y
5Y
10Y
15Y
AZTR
21.11.2021 - 28.11.2021

Azitra, Inc., an early-stage biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. It develops ATR-12, a genetically modified strain of S. epidermidis, which is in Phase Ib clinical trial for treating Netherton syndrome, a skin disease. The company also develops ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash experienced by cancer patients undergoing epidermal growth factor receptor inhibitor; and ATR-01, an engineered recombinant human filaggrin protein for treating ichthyosis vulgaris, a skin disease. It has a collaboration with Bayer. The company was incorporated in 2014 and is based in Branford, Connecticut. Address: 21 Business Park Drive, Branford, CT, United States, 06405

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

3.5 USD

P/E ratio

0.0053

Dividend Yield

Current Year

+686 000 USD

Last Year

+284 000 USD

Current Quarter

+7 500 USD

Last Quarter

+90 000 USD

Current Year

+260 451 USD

Last Year

-121 977 USD

Current Quarter

-106 440 USD

Last Quarter

-114 913 USD

Key Figures AZTR

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -10 122 036 USD
Operating Margin TTM -35470.4 %
PE Ratio 0.0053
Return On Assets TTM -93.46 %
PEG Ratio
Return On Equity TTM -222.3 %
Wall Street Target Price 3.5 USD
Revenue TTM 408 200 USD
Book Value 1.8 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -95.6 %
Dividend Yield
Gross Profit TTM 284 000 USD
Earnings per share 92.33 USD
Diluted Eps TTM 92.33 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics AZTR

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History AZTR

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:30
Payout Ratio
Last Split Date 01.07.2024
Dividend Date

Stock Valuation AZTR

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 0.0053
Forward PE
Enterprise Value Revenue 8.8732
Price Sales TTM 9.0702
Enterprise Value EBITDA -0.3876
Price Book MRQ 2.1449

Financials AZTR

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators AZTR

For 52 weeks

0.46 USD 68.4 USD
50 Day MA 0.56 USD
Shares Short Prior Month 119 587
200 Day MA 6.59 USD
Short Ratio 0.79
Shares Short 237 661
Short Percent 3.41 %